SCHEMBL6300802

SCHEMBL6300802

COc1ccc2[nH]c(-c3ccccc3Cl)c(C(=O)O)c(=O)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.54
CHEK1 O14757 1/20 0.51
WEE1 P30291 1/20 0.51
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 4/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300675 0.86 ABCG2 (0.54) ABCG2ALDH1A1KDM4EPOLBGAA
SCHEMBL6294584 0.86 ALOX5 (0.57) ABCG2CHEK1WEE1ALDH1A1KDM4E
SCHEMBL6300691 0.86 TUBB4A (0.62) ABCG2ALDH1A1KDM4EPOLBGAA
SCHEMBL6295963 0.84 MAP2 (0.47) ALDH1A1KDM4EMDH2MEN1KMT2A
SCHEMBL6295986 0.82 KDM4E (0.51) ALDH1A1KDM4EGAATDP1TUBB4A
SCHEMBL6294655 0.82 ABCG2 (0.51) ABCG2ALDH1A1KDM4EPOLBGAA
SCHEMBL6300415 0.81 ABCG2 (0.56) ABCG2ALDH1A1KDM4EPOLBGAA
SCHEMBL6300558 0.80 MAP2 (0.56) POLBGAATUBB4ATUBBTUBA3C
SCHEMBL6295747 0.78 ABCG2 (0.51) ABCG2ALDH1A1KDM4EPOLBGAA
SCHEMBL6296013 0.77 ALDH1A1 (0.60) ABCG2ALDH1A1KDM4EPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK ABCG2 26/4885CHEK1 87/4885WEE1 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.